Skip to main content
SAMIL PHARMACEUTICAL CO.,LTD logo

SAMIL PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000520 ISIN · KR7000520007 KO Manufacturing
Open in API
Filings indexed 336 across all filing types
Latest filing 2023-03-09 AGM Information
Country KR South Korea
Listing KO 000520

About SAMIL PHARMACEUTICAL CO.,LTD

https://www.samil-pharm.com/main/EN

Samil Pharmaceutical Co., Ltd. is a company engaged in the research, development, and manufacturing of pharmaceutical products. The company specializes in ophthalmology and also produces a diverse portfolio of drugs for other therapeutic areas, including the central nervous system (CNS), hepatic conditions, and gastrointestinal disorders. Its product range encompasses prescription medicines as well as over-the-counter remedies for common ailments like fever and colds. In addition to developing its own products, Samil Pharmaceutical offers Contract Development and Manufacturing Organization (CDMO) services to global partners. The company emphasizes research and development and collaborates with other leading pharmaceutical firms.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Samil Pharmaceutical. It contains the meeting agenda, details on voting procedures (including electronic voting), and management information such as board activities and financial statements for the 70th fiscal year. This type of document is specifically prepared for shareholders to inform them of the upcoming AGM and provide necessary materials for voting, which falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-09 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) by Samil Pharmaceutical regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with many other companies' AGMs, citing audit schedules and logistical constraints. Since this is a specific regulatory disclosure regarding meeting logistics and does not fit into the other categories like AGM-R (presentation materials) or PSI (proxy solicitation), it is best classified as a general regulatory filing.
2023-03-09 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains the agenda, proxy solicitation details, and financial statements (balance sheet, income statement, etc.) as required by law for shareholders to make informed voting decisions. This falls under the 'Proxy Solicitation & Information Statement' category.
2023-03-09 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy) and includes a '정정신고' (Correction Report) header. It contains detailed information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, proxy solicitation details, and financial statements provided as reference materials for shareholders to exercise their voting rights. This is a standard proxy solicitation document used to request shareholder votes for an AGM.
2023-03-09 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the exchange price for convertible bonds (exchangeable bonds) issued by Samil Pharmaceutical. This type of filing, which details changes to the conversion or exercise price of equity-linked securities due to market price fluctuations, is classified as a capital structure update. In the provided taxonomy, 'SHA' (Share Issue/Capital Change) is the most appropriate category for announcements involving changes to the terms of equity-linked securities that affect potential share issuance.
2023-03-09 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a 'General Meeting of Shareholders' (주주총회소집결의) issued by Samil Pharmaceutical. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and amendments to business purposes. This type of document is a standard proxy solicitation/information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2023-02-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.